Format

Send to

Choose Destination
See comment in PubMed Commons below
Manag Care Interface. 2007 Apr;20(4):20-7.

Incremental treatment expenditure of diabetes in the United States.

Author information

1
HERQuLES, Abt Associates, Inc., Lexington, Massachusetts 02421, USA. sanjeev_balu@abtassoc.com

Abstract

The 2004 Medical Expenditure Panel Survey, a national probability sample survey of the civilian noninstitutionalized U.S. population, analyzed incremental direct expenditures of treating diabetes in the United States. Patients with diabetes were identified as those with a medical diagnosis for diabetes based on International Classification of Diseases, Ninth Revision, codes, as well as those who consumed diabetes-related medical care services, self-reported being diagnosed with diabetes by their physician, and were prescribed an antidiabetic medication. Incremental expenditure of treating diabetes was estimated through least squares regression. Sample estimates projected to the population indicated that approximately 4.4% of individuals aged 18 years and older in the ambulatory population have diabetes. Total incremental annual direct expenditures for patients with diabetes were estimated to be more than $82.0 billion in 2004. Diabetes expenditures represent a significant amount of health care resource utilization.

PMID:
17474327
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center